Perspectives series: host/pathogen interactions. Dynamics of HIV-1 replication in vivo.

Por Ho, D D
Publicado em 1997

Therapy of HIV infections: problems and prospects.

Por Ho, D. D.
Publicado em 1996

Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro.

Por Spira, A I, Ho, D D
Publicado em 1995

Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype.

Por Wang, N, Zhu, T, Ho, D D
Publicado em 1995

Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.

Por Connor, R I, Ho, D D
Publicado em 1994

Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.

Por Moore, J P, Ho, D D
Publicado em 1993

Pathogenesis of human immunodeficiency virus infection and prospects for control.

Por Ho, D. D., Kaplan, J. C.
Publicado em 1987

Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection.

Por Huang, Y, Zhang, L, Ho, D D
Publicado em 1995

Biological characterization of nef in long-term survivors of human immunodeficiency virus type 1 infection.

Por Huang, Y, Zhang, L, Ho, D D
Publicado em 1995

Infection of human endothelial cells by human T-lymphotropic virus type I.

Por Ho, D D, Rota, T R, Hirsch, M S
Publicado em 1984

Infection of monocyte/macrophages by human T lymphotropic virus type III.

Por Ho, D D, Rota, T R, Hirsch, M S
Publicado em 1986

Genotyping HIV-1 and HCV strains by a combinatorial DNA melting assay (COMA).

Por Kostrikis, L. G., Shin, S., Ho, D. D.
Publicado em 1998

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.

Por Daar, E S, Li, X L, Moudgil, T, Ho, D D
Publicado em 1990

Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor.

Por Zhu, T, Wang, N, Carr, A, Wolinsky, S, Ho, D D
Publicado em 1995

Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients.

Por Mohri, H, Singh, M K, Ching, W T, Ho, D D
Publicado em 1993

Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase.

Por Goudsmit, J, De Ronde, A, Ho, D D, Perelson, A S
Publicado em 1996

Characterization of mutants of human immunodeficiency virus type 1 that have escaped neutralization by a monoclonal antibody to the gp120 V2 loop.

Por Yoshiyama, H, Mo, H, Moore, J P, Ho, D D
Publicado em 1994

Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.

Por Connor, R I, Mohri, H, Cao, Y, Ho, D D
Publicado em 1993

CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1.

Por Li, X L, Moudgil, T, Vinters, H V, Ho, D D
Publicado em 1990

Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1.

Por Moore, J P, Cao, Y, Ho, D D, Koup, R A
Publicado em 1994